| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.273.9.4909 |
| P698 | PubMed publication ID | 9478934 |
| P2093 | author name string | Tong Q | |
| Jhiang SM | |||
| Xing S | |||
| Furminger TL | |||
| P2860 | cites work | Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B | Q24309625 |
| The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma | Q24310718 | ||
| A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor | Q24311883 | ||
| GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF | Q24329169 | ||
| Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor | Q24561804 | ||
| Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A | Q24611227 | ||
| Direct association between the Ret receptor tyrosine kinase and the Src homology 2-containing adapter protein Grb7 | Q28278965 | ||
| Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase | Q28283499 | ||
| Identification of Shc docking site on Ret tyrosine kinase | Q28304464 | ||
| Catalytic specificity of protein-tyrosine kinases is critical for selective signalling | Q29616451 | ||
| Mitogen-activated protein kinase pathways | Q29618431 | ||
| Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations | Q36550021 | ||
| An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway | Q36644261 | ||
| A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. | Q37451018 | ||
| Regulatory elements in the promoter region of vgf, a nerve growth factor-inducible gene | Q37599132 | ||
| Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase. | Q41105131 | ||
| Glial cell line-derived neurotrophic factor induces Ret-mediated lamellipodia formation | Q41135268 | ||
| Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase | Q41166310 | ||
| GDNF signalling through the Ret receptor tyrosine kinase | Q41190484 | ||
| Functional receptor for GDNF encoded by the c-ret proto-oncogene | Q41190489 | ||
| Leucine zipper-mediated dimerization is essential for the PTC1 oncogenic activity | Q42801886 | ||
| A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins | Q42810812 | ||
| Mitogenic signaling by Ret/ptc2 requires association with enigma via a LIM domain | Q42812834 | ||
| Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations | Q44233386 | ||
| Mutations of theRET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease | Q57591326 | ||
| Nerve growth factor stimulates GAP-43 expression in PC12 cell clones independently of neurite outgrowth | Q71604294 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phaeochromocytoma | Q536269 |
| P304 | page(s) | 4909-4914 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Signal transduction pathways activated by RET oncoproteins in PC12 pheochromocytoma cells | |
| P478 | volume | 273 |
| Q33757079 | Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma |
| Q40726263 | Activation of RET tyrosine kinase regulates interleukin-8 production by multiple signaling pathways |
| Q35445077 | Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer |
| Q24563513 | Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells |
| Q40852922 | Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor |
| Q40313679 | Cholecystokinin 1 receptor modulates the MEKK1-induced c-Jun trans-activation: structural requirements of the receptor |
| Q40655621 | Corticotropin‐Releasing Hormone (CRH) Expression and Protein Kinase A Mediated CRH Receptor Signalling in an Immortalized Hypothalamic Cell Line |
| Q40835424 | Differential effects of leukocyte common antigen-related protein on biochemical and biological activities of RET-MEN2A and RET-MEN2B mutant proteins |
| Q50067512 | Genetic and Epigenetic of Medullary Thyroid Cancer |
| Q55008552 | Genetic and Epigenetic of Medullary Thyroid Cancer. |
| Q40688618 | Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation |
| Q36729440 | HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo |
| Q40654307 | Internalization of glial cell-derived neurotrophic factor receptor GFR alpha 1 in the absence of the ret tyrosine kinase coreceptor |
| Q44004710 | Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece |
| Q35170203 | Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury |
| Q42792243 | Nuclear envelope irregularity is induced by RET/PTC during interphase |
| Q42795947 | Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells |
| Q34360698 | The GDNF/RET signaling pathway and human diseases |
| Q38814755 | The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2A. |
| Q34103632 | The RET proto-oncogene in human cancers |
| Q34565449 | The contribution of associated congenital anomalies in understanding Hirschsprung's disease |
| Q44224232 | The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation |
| Q34012396 | The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis |
| Q28141552 | The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas |
Search more.